Genetics Generation Advancement Corp.
4160
Rank in Stocks
#24906
Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan,... Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners. Beyond its core genetic services, Genetics Generation Advancement Corp. extends its expertise to encompass life sciences, materials science, sophisticated laboratory informatics, enterprise quality management systems (EQMS), Manufacturing Execution Systems (MES), and efficient electronic data delivery solutions. Originally founded in 2008 as Genesis Genetics Asia Corp., the company officially rebranded and adopted its current name, Genetics Generation Advancement Corp., in February 2016.
Share Price
$1.06
Last synced: 2026-11-10
Market Cap
$29.68M
Change (1 day)
0.14%
Change (1 year)
-38.17%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genetics Generation Advancement Corp. (4160)
Category
Healthcare
Operating Margin for Genetics Generation Advancement Corp. (4160)
Operating Margin as of November 2026 TTM: 0.29%
According to Genetics Generation Advancement Corp.'s latest financial reports, its current operating margin (TTM) is 0.29%. At the end of 2025 the company had an operating margin of 1.96%.
Operating Margin history for Genetics Generation Advancement Corp. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.29% | -85.20% |
| 2025 | 1.96% | -73.80% |
| 2024 | 7.48% | 138.22% |
| 2023 | 3.14% | -49.44% |
| 2022 | 6.21% | 215.23% |
| 2021 | 1.97% | -148.40% |
| 2020 | -4.07% | -254.75% |
| 2019 | 2.63% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -38.00% |
US
|
|
| 20.38% | -29.72% |
US
|
|
| 43.02% | 48.34% |
CN
|
|
| 32.03% | 10.45% |
US
|
|
| 22.23% | -23.34% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Genetics Generation Advancement Corp.'s operating margin
What is Genetics Generation Advancement Corp.'s operating margin?
Genetics Generation Advancement Corp.'s operating margin is 0.29%, as of Nov 2026.
What was Genetics Generation Advancement Corp.'s operating margin in 2025?
In 2025, Genetics Generation Advancement Corp.'s operating margin was 1.96%, compared with 7.48% in 2024.
How has Genetics Generation Advancement Corp.'s operating margin changed since 2020?
From 2020 to 2025, Genetics Generation Advancement Corp.'s operating margin was highest in 2024 (7.48%) and lowest in 2020 (-4.07%).
How does Genetics Generation Advancement Corp.'s operating margin compare with similar companies?
Genetics Generation Advancement Corp.'s operating margin (0.29%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.